Apogee Therapeutics, Inc. Net Fee Amt
Apogee Therapeutics, Inc. (APGE) had Net Fee Amt of $1.50 million as of 2026-07-02, per its PREM14A filed 2026-07-02.
Financial Statements › Notes
ffd:NetFeeAmt · last filed 2026-07-02
- 2026-07-02: Net Fee Amt $1.50M.
| Period end | Net Fee Amt |
|---|---|
| 2026-07-02 | $1.50M PREM14A · filed 2026-07-02 |